Kepivance(TM) (palifermin) Receives Positive Regulatory Opinion for Approval in Europe Read more about Kepivance(TM) (palifermin) Receives Positive Regulatory Opinion for Approval in Europe
Abgenix and Amgen Announce FDA Grants Panitumumab Fast Track Designation for Metastatic Colorectal Cancer Read more about Abgenix and Amgen Announce FDA Grants Panitumumab Fast Track Designation for Metastatic Colorectal Cancer
Further Phase 2 Data Confirm Panitumumab Single-Agent Antitumor Activity in Patients with Metastatic Colorectal Cancer Read more about Further Phase 2 Data Confirm Panitumumab Single-Agent Antitumor Activity in Patients with Metastatic Colorectal Cancer
Interim Data Suggest Major Response with Aranesp(R) in Anemic Patients with Myelodysplastic Syndromes (MDS) Read more about Interim Data Suggest Major Response with Aranesp(R) in Anemic Patients with Myelodysplastic Syndromes (MDS)
Amgen's Second Quarter 2005 Adjusted Earnings Per Share Increased 42 Percent to 88 Cents Read more about Amgen's Second Quarter 2005 Adjusted Earnings Per Share Increased 42 Percent to 88 Cents
Amgen Announces Webcast of Second Quarter Financial Results Read more about Amgen Announces Webcast of Second Quarter Financial Results
FDA Expands ENBREL Psoriatic Arthritis Indication -- ENBREL Approved as First and Only Treatment to Improve Physical Function in These Patients Read more about FDA Expands ENBREL Psoriatic Arthritis Indication -- ENBREL Approved as First and Only Treatment to Improve Physical Function in These Patients
2005 Recipients of Amgen Award for Science Teaching Excellence Announced; 19 Outstanding Science Teachers and Their Schools Recognized in Communities Across U.S. and Puerto Rico Read more about 2005 Recipients of Amgen Award for Science Teaching Excellence Announced; 19 Outstanding Science Teachers and Their Schools Recognized in Communities Across U.S. and Puerto Rico
Amgen Names Jim Daly, Senior Vice President, North America Commercial Operations Read more about Amgen Names Jim Daly, Senior Vice President, North America Commercial Operations
Large Community-Based Clinical Trial in Older Cancer Patients Suggests Benefits of Neulasta in First and Subsequent Cycles Of Chemotherapy Read more about Large Community-Based Clinical Trial in Older Cancer Patients Suggests Benefits of Neulasta in First and Subsequent Cycles Of Chemotherapy
